Dimensional Fund Advisors’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,161,964
Closed -$27.4M 3444
2023
Q4
$27.4M Hold
1,161,964
0.01% 1824
2023
Q3
$17.3M Sell
1,161,964
-5,449
-0.5% -$81.3K 0.01% 2005
2023
Q2
$12.8M Sell
1,167,413
-15,823
-1% -$173K ﹤0.01% 2146
2023
Q1
$10.3M Sell
1,183,236
-131,286
-10% -$1.14M ﹤0.01% 2221
2022
Q4
$8.24K Buy
1,314,522
+67,157
+5% +$421 ﹤0.01% 2283
2022
Q3
$4.37M Buy
1,247,365
+169,679
+16% +$594K ﹤0.01% 2473
2022
Q2
$3.18M Buy
1,077,686
+136,880
+15% +$404K ﹤0.01% 2598
2022
Q1
$2.93M Buy
940,806
+145,965
+18% +$454K ﹤0.01% 2714
2021
Q4
$2.69M Buy
794,841
+16,726
+2% +$56.5K ﹤0.01% 2771
2021
Q3
$2.84M Sell
778,115
-382,994
-33% -$1.4M ﹤0.01% 2745
2021
Q2
$5.06M Sell
1,161,109
-161,083
-12% -$702K ﹤0.01% 2606
2021
Q1
$6M Buy
1,322,192
+70,206
+6% +$319K ﹤0.01% 2509
2020
Q4
$7.19M Buy
1,251,986
+207,251
+20% +$1.19M ﹤0.01% 2393
2020
Q3
$7.56M Buy
1,044,735
+134,432
+15% +$973K ﹤0.01% 2321
2020
Q2
$3.18M Sell
910,303
-149,228
-14% -$521K ﹤0.01% 2611
2020
Q1
$1.57M Sell
1,059,531
-34,354
-3% -$50.8K ﹤0.01% 2785
2019
Q4
$2.14M Sell
1,093,885
-50,631
-4% -$99.2K ﹤0.01% 2840
2019
Q3
$5.86M Buy
1,144,516
+28,657
+3% +$147K ﹤0.01% 2550
2019
Q2
$7.99M Buy
1,115,859
+63,793
+6% +$457K ﹤0.01% 2474
2019
Q1
$14M Buy
1,052,066
+335,092
+47% +$4.45M 0.01% 2246
2018
Q4
$5.64M Buy
716,974
+370,985
+107% +$2.92M ﹤0.01% 2569
2018
Q3
$3.83M Buy
+345,989
New +$3.83M ﹤0.01% 2762